{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:02:36Z","timestamp":1790960556089,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/md.0000000000006737","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T16:31:42Z","timestamp":1496248302000},"page":"e6737","source":"Crossref","is-referenced-by-count":5,"title":["Successful treatment of infliximab in a patient with scleroderma"],"prefix":"10.1097","volume":"96","author":[{"given":"Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210309","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"R2-3-20210309","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1756-185X.2012.01755.x","article-title":"Serum leptin, resistin and TNF-\u03b1 levels in patients with systemic sclerosis: the role of adipokines in scleroderma","volume":"15","author":"Pehlivan","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"R3-3-20210309","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10875-013-9889-y","article-title":"TNF-\u03b1-secreting B cells contribute to myocardial fibrosis in dilated cardiomyopathy","volume":"33","author":"Yu","year":"2013","journal-title":"J Clin Immunol"},{"key":"R4-3-20210309","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.37738","article-title":"Tumor necrosis factor\u2013costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts","volume":"65","author":"H\u00fcgle","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R5-3-20210309","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/imt.13.173","article-title":"Potential use of TNF-\u03b1 inhibitors in systemic sclerosis","volume":"6","author":"Murdaca","year":"2014","journal-title":"Immunotherapy"},{"key":"R6-3-20210309","first-page":"1636","article-title":"Efficacy and safety of etanercept in the treatment of scleroderma-associated joint disease","volume":"34","author":"Lam","year":"2007","journal-title":"J Rheumatol"},{"key":"R7-3-20210309","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/ard.2008.096123","article-title":"An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis","volume":"68","author":"Denton","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R8-3-20210309","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/art.23645","article-title":"The controversial role of tumor necrosis factor \u03b1 in fibrotic diseases","volume":"58","author":"Distler","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R9-3-20210309","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1902\/jop.2012.120225","article-title":"Tumor necrosis factor-\u03b1 inhibits transforming growth factor-\u03b2-stimulated myofibroblastic differentiation and extracellular matrix production in human gingival fibroblasts","volume":"84","author":"Arancibia","year":"2013","journal-title":"J Periodontol"},{"key":"R10-3-20210309","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/138920101506140910150749","article-title":"Biologics in systemic sclerosis","volume":"15","author":"Xuan","year":"2014","journal-title":"Curr Pharm Biotechnol"},{"key":"R11-3-20210309","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar4334","article-title":"Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts","volume":"15","author":"Brembilla","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R12-3-20210309","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.329.7477.1266","article-title":"Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab","volume":"329","author":"Ostor","year":"2004","journal-title":"BMJ"},{"key":"R13-3-20210309","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2005.044453","article-title":"Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:48:31Z","timestamp":1620960511000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201706020-00003"}},"subtitle":["a case report"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":13,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006737","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}